The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
The iCRISPR Platform for Rapid Genome Editing in Human Pluripotent Stem Cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“The technique also allows DNA sequence changes in pluripotent embryonic stem cells (4) that can then be cultured to produce specific tissues, such as cardiomyocytes or neurons (5).”
From A prudent path forward for genomic engineering and germline gene modification (2015) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
CRISPR-Mediated Modular RNA-Guided Regulation of Transcription in Eukaryotes
Gilbert, L. A., Larson, M. H., Morsut, L., Liu, Z., Brar, G. A., Torres, S. E., Stern-Ginossar, N., Brandman, O., Whitehead, E. H., Doudna, J. A., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.044 · Cited by 3,696 · cited 1×
“Also, by replacing Cas9 with other Cas9 variants such as dCas9, dCas9-KRAB or dCas9-VP16 (Gilbert et al., 2013; Qi et al., 2013), one may repurpose iCRISPR for gene regulation.”
MethodWang, H., Yang, H., Shivalila, C. S., Dawlaty, M. M., Cheng, A. W., Zhang, F., & Jaenisch, R. (2013) · Cell · doi:10.1016/j.cell.2013.04.025 · Cited by 3,495
High-Frequency off-Target Mutagenesis Induced by CRISPR-Cas Nucleases in Human Cells
Fu, Y., Foden, J. A., Khayter, C., Maeder, M. L., Reyon, D., Joung, J. K., & Sander, J. D. (2013) · Nature Biotechnology · doi:10.1038/nbt.2623 · Cited by 3,292
Mali, P., Aach, J., Stranges, P. B., Esvelt, K. M., Moosburner, M., Kosuri, S., Yang, L., & Church, G. M. (2013) · Nature Biotechnology · doi:10.1038/nbt.2675 · Cited by 1,752 · cited 3×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript et al., 2013b; Fu et al., 2013; Hsu et al., 2013; Mali et al., 2013a; Pattanayak et al., 2013).”
BackgroundTALENs: A widely applicable technology for targeted genome editing
Joung, J. K., & Sander, J. D. (2013) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3486 · Cited by 1,650 · cited 1×
“The development of programmable site-specific nucleases has significantly facilitated targeted genome editing in a wide range of organisms and cultured cell types (Joung and Sander, 2013; Ran et al., 2013; Urnov et al., 2010).”
BackgroundPattanayak, V., Lin, S., Guilinger, J. P., Ma, E., Doudna, J. A., & Liu, D. R. (2013) · Nature Biotechnology · doi:10.1038/nbt.2673 · Cited by 1,487 · cited 4×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript et al., 2013b; Fu et al., 2013; Hsu et al., 2013; Mali et al., 2013a; Pattanayak et al., 2013).”
BackgroundInfluentialFeeder-independent culture of human embryonic stem cells
Ludwig, T. E., Bergendahl, V., Levenstein, M. E., Yu, J., Probasco, M. D., & Thomson, J. A. (2006) · Nature Methods · doi:10.1038/nmeth902 · Cited by 681 · cited 1×
“It may be necessary to adjust the following protocol for hPSCs cultured under different conditions such such as the feeder-free TeSR and Essential 8 culture conditions (Chen et al., 2011b; Ludwig et al., 2006).”
BackgroundVeres, A., Gosis, B. S., Ding, Q., Collins, R., Ragavendran, A., Brand, H., Erdin, S., Cowan, C. A., Talkowski, M. E., & Musunuru, K. (2014) · Cell Stem Cell · doi:10.1016/j.stem.2014.04.020 · Cited by 474
Smith, C., Gore, A., Yan, W., Abalde-Atristain, L., Li, Z., He, C., Wang, Y., Brodsky, R. A., Zhang, K., Cheng, L., et al. (2014) · Cell stem cell · doi:10.1016/j.stem.2014.06.011 · Cited by 342
Research works printed but not linked: 41
- An, 2014, Polyglutamine disease modeling: Epitope based screen for homologous recombination using CRISPR/Cas9 system, PLoS Currents, 6
- Bae, 2014, Microhomology-based choice of Cas9 nuclease target sites, Nature Methods, 11, 705, 10.1038/nmeth.3015 · DOI
- Boch, 2009, Breaking the code of DNA binding specificity of TAL-type III effectors, Science, 326, 1509, 10.1126/science.1178811 · DOI · Paper page
- Cermak, 2011, Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targeting, Nucleic Acids Research, 39, e82, 10.1093/nar/gkr218 · DOI
- Chen, 2011, Chemically defined conditions for human iPSC derivation and culture, Nature Methods, 8, 424, 10.1038/nmeth.1593 · DOI · Paper page
- Chen, 2011, High-frequency genome editing using ssDNA oligonucleotides with zinc-finger nucleases, Nature Methods, 8, 753, 10.1038/nmeth.1653 · DOI
- Cho, 2013, Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease, Nature Biotechnology, 31, 230, 10.1038/nbt.2507 · DOI · Paper page
- Cho, 2014, Analysis of off-target effects of CRISPR/Cas-derived RNA-guided endonucleases and nickases, Genome Research, 24, 132, 10.1101/gr.162339.113 · DOI · Paper page
- Cong, 2013, Multiplex genome engineering using CRISPR/Cas systems, Science, 339, 819, 10.1126/science.1231143 · DOI · Paper page
- Costa, 2007, A method for genetic modification of human embryonic stem cells using electroporation, Nature Protocols, 2, 792, 10.1038/nprot.2007.105 · DOI
- Davis, 2008, A protocol for removal of antibiotic resistance cassettes from human embryonic stem cells genetically modified by homologous recombination or transgenesis, Nature Protocols, 3, 1550, 10.1038/nprot.2008.146 · DOI
- DeKelver, 2010, Functional genomics, proteomics, and regulatory DNA analysis in isogenic settings using zinc finger nuclease-driven transgenesis into a safe harbor locus in the human genome, Genome Research, 20, 1133, 10.1101/gr.106773.110 · DOI
- Ding, 2013, Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs, Cell Stem Cell, 12, 393, 10.1016/j.stem.2013.03.006 · DOI · Paper page
- Gonzalez, 2014, An iCRISPR platform for rapid, multiplexable, and inducible genome editing in human pluripotent stem cells, Cell Stem Cell, 15, 215, 10.1016/j.stem.2014.05.018 · DOI
- Hockemeyer, 2011, Genetic engineering of human pluripotent cells using TALE nucleases, Nature Biotechnology, 29, 731, 10.1038/nbt.1927 · DOI
- Horii, 2013, Generation of an ICF syndrome model by efficient genome editing of human induced pluripotent stem cells using the CRISPR system, International Journal of Molecular Sciences, 14, 19774, 10.3390/ijms141019774 · DOI · Paper page
- Hou, 2013, Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis, Proceedings of the National Academy of Sciences of the United States of America, 110, 15644, 10.1073/pnas.1313587110 · DOI · Paper page
- Hsu, 2013, DNA targeting specificity of RNA-guided Cas9 nucleases, Nature Biotechnology, 31, 827, 10.1038/nbt.2647 · DOI · Paper page
- Ito, 2010, Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification, Nature, 466, 1129, 10.1038/nature09303 · DOI
- Jasin, 1996, Genetic manipulation of genomes with rare-cutting endonucleases, Trends in Genetics, 12, 224, 10.1016/0168-9525(96)10019-6 · DOI
- Jinek, 2012, A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity, Science, 337, 816, 10.1126/science.1225829 · DOI · Paper page
- Jinek, 2013, RNA-programmed genome editing in human cells, eLife, 2, e00471, 10.7554/eLife.00471 · DOI · Paper page
- Ma, 2014, Generation of eGFP and Cre knockin rats by CRISPR/Cas9, The FEBS Journal, 281, 3779, 10.1111/febs.12935 · DOI
- Mali, 2013, RNA-guided human genome engineering via Cas9, Science, 339, 823, 10.1126/science.1232033 · DOI · Paper page
- Miller, 2011, A TALE nuclease architecture for efficient genome editing, Nature Biotechnology, 29, 143, 10.1038/nbt.1755 · DOI · Paper page
- Moscou, 2009, A simple cipher governs DNA recognition by TAL effectors, Science, 326, 1501, 10.1126/science.1178817 · DOI
- Qi, 2013, Repurposing CRISPR as an RNA-guided platform for sequence-specific control of gene expression, Cell, 152, 1173, 10.1016/j.cell.2013.02.022 · DOI · Paper page
- Ran, 2013, Genome engineering using the CRISPR-Cas9 system, Nature Protocols, 8, 2281, 10.1038/nprot.2013.143 · DOI · Paper page
- Rossier, 1999, The Xanthomonas Hrp type III system secretes proteins from plant and mammalian bacterial pathogens, Proceedings of the National Academy of Sciences of the United States of America, 96, 9368, 10.1073/pnas.96.16.9368 · DOI
- Rouet, 1994, Introduction of double-strand breaks into the genome of mouse cells by expression of a rare-cutting endonuclease, Molecular and Cellular Biology, 14, 8096, 10.1128/MCB.14.12.8096 · DOI
- Sanjana, 2012, A transcription activator-like effector toolbox for genome engineering, Nature Protocols, 7, 171, 10.1038/nprot.2011.431 · DOI
- Smith, 2008, Robust, persistent transgene expression in human embryonic stem cells is achieved with AAVS1-targeted integration, Stem Cells, 26, 496, 10.1634/stemcells.2007-0039 · DOI
- Suzuki, 2014, Targeted gene correction minimally impacts whole-genome mutational load in human-disease-specific induced pluripotent stem cell clones, Cell Stem Cell, 15, 31, 10.1016/j.stem.2014.06.016 · DOI · Paper page
- Szurek, 2001, Eukaryotic features of the Xanthomonas type III effector AvrBs3: Protein domains involved in transcriptional activation and the interaction with nuclear import receptors from pepper, The Plant Journal, 26, 523, 10.1046/j.0960-7412.2001.01046.x · DOI
- Tahiliani, 2009, Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1, Science, 324, 930, 10.1126/science.1170116 · DOI · Paper page
- Urnov, 2010, Genome editing with engineered zinc finger nucleases, Nature Reviews Genetics, 11, 636, 10.1038/nrg2842 · DOI · Paper page
- van der Oost, 2014, Unravelling the structural and mechanistic basis of CRISPR-Cas systems, Nature Reviews Microbiology, 12, 479, 10.1038/nrmicro3279 · DOI
- Wang, 2014, Modeling the mitochondrial cardiomyopathy of Barth syndrome with induced pluripotent stem cell and heart-on-chip technologies, Nature Medicine, 20, 616, 10.1038/nm.3545 · DOI · Paper page
- Yang, 2013, One-step generation of mice carrying reporter and conditional alleles by CRISPR/Cas-mediated genome engineering, Cell, 154, 1370, 10.1016/j.cell.2013.08.022 · DOI · Paper page
- Ye, 2014, Seamless modification of wild-type induced pluripotent stem cells to the natural CCR5Delta32 mutation confers resistance to HIV infection, Proceedings of the National Academy of Sciences of the United States of America, 111, 9591, 10.1073/pnas.1407473111 · DOI · Paper page
- Zhu, 2013, Human pluripotent stem cells: An emerging model in developmental biology, Development, 140, 705, 10.1242/dev.086165 · DOI
Cited by
Sorted by citations
Efficient introduction of specific homozygous and heterozygous mutations using CRISPR/Cas9
Paquet, D., Kwart, D., Chen, A., Sproul, A., Jacob, S., Teo, S., Olsen, K. M., Gregg, A., Noggle, S., & Tessier-Lavigne, M. (2016) · Nature · doi:10.1038/nature17664 · Cited by 951
A prudent path forward for genomic engineering and germline gene modification
Baltimore, D., Berg, P., Botchan, M., Carroll, D., Charo, R. A., Church, G., Corn, J. E., Daley, G. Q., Doudna, J. A., Fenner, M., et al. (2015) · Science · doi:10.1126/science.aab1028 · Cited by 733
Metadata
- Authors
- Zhu, Z., González, F., & Huangfu, D.
- Venue
- Methods in Enzymology
- Publisher
- Elsevier
- Published
- 2014
- Pages
- 215-250
- ISSN
- 0076-6879
- PMC
- PMC4418970
- Cited by
- 66
- References
- 9
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
